Evidence of depressive symptoms in fragile-X syndrome premutated females

Psychiatric Genetics

Volumn 18, Issue 4, 2008, Pages 153-155

  Rodriguez Revenga, Laia ^a,b,c   Madrigal, Irene ^a   Alegret, Montserrat ^b   Santos, Mónica ^a,b   Milà, Montserrat ^a,b  

^a HOSPITAL CLÍNIC   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c Institut Catala de Neurociencies Aplicades   (Spain)

Author keywords

Depression; Fragile X syndrome; Neuropsychiatric phenotype; Premutation carrier

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DEPRESSION; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FEMALE; FRAGILE X SYNDROME; GENE MUTATION; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; MOTHER; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; SYMPTOM; CASE CONTROL STUDY; GENETICS; MUTATION; PSYCHOLOGICAL RATING SCALE;

ADULT; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; FRAGILE X SYNDROME; HUMANS; MUTATION; PSYCHIATRIC STATUS RATING SCALES;

EID: 50349103445     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3282f97e0b     Document Type: Article

References (15)

1. Beck AT, Steer RA, Garbin MG (1988). Psychometric properties of the Beck Depression Inventory: 25 years of evaluation. Clin Psychol Rev 8:77-100.
2. Derogatis LR (1997). Symptom checklist-90-R. Administration, scoring, and procedures manual. Minneapolis: National Computer Systems, Inc.
3. Franke P, Leboyer M, Gansicke M, Weiffenbach O, Biancalana V, Cornillet-Lefebre P, et al. (1998). Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res 80: 113-127.
4. Freund LS, Reiss AL, Hagerman R, Vinogradov S (1992). Chromosome fragility and psychopathology in obligate female carriers of the fragile X chromosome. Arch Gen Psychiatry 49:54-60.
5. Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, et al. (1991). Variation of the CGG repeat at the Fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-1058.
6. Hagerman PJ, Hagerman RJ (2004). The fragile-X premutation: a maturing perspective. Am J Hum Genet 74:805-816.
7. Hessl D, Tassone F, Loesch DZ, Berry-Kravis E, Leehey MA, Gane LW, et al. (2005). Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet 139:115-121.
8. Johnston C, Eliez S, Dyer-Friedman J, Hessl D, Glaser B, Blasey C, et al. (2001). Neurobehavioral phenotype in carriers of the fragile X premutation. Am J Med Genet 103:314-319.
9. Moore CJ, Daly EM, Schmitz N, Tassone F, Tysoe C, Hagerman RJ, et al. (2004). A neuropsychological investigation of male premutation carriers of fragile X syndrome. Neuropsychologia 42:1934-1947.
10. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, et al. (1991). Absence of expression of the FMR1 gene in Fragile X syndrome. Cell 66:817-822.
11. Reiss AL, Freund L, Abrams MT, Boehm C, Kazazian H (1993). Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet 52:884-894.
12. Sobesky WE, Taylor AK, Pennington BF, Bennetto L, Porter D, Riddle J, et al. (1996). Molecular/clinical correlations in females with fragile X. Am J Med Genet 64:340-345.
13. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ (2000). Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am J Hum Genet 66:6-15.
14. Thompson NM, Gulley ML, Rogeness GA, Clayton RJ, Johnson C, Hazelton B, et al. (1994). Neurobehavioral characteristics of CGG amplification status in fragile X females. Am J Med Genet 54:378-383.
15. Turner G, Webb T, Wake S, Robinson H (1996). Prevalence of fragile X syndrome. Am J Med Genet 64:196-197.